doc. MUDr. Igor Kiss, Ph.D., MBA
Department head, Comprehensive Cancer Care Department
Total number of publications: 247
2023
-
FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer
Cancers, year: 2023, volume: 15, edition: 6, DOI
-
Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma
Targeted Oncology, year: 2023, volume: 18, edition: November 2023, DOI
-
The risk of second primary malignancies in colorectal cancer patients using calcium channel blockers
SCIENTIFIC REPORTS, year: 2023, volume: 13, edition: 1, DOI
-
Vliv chemoterapie a následného intervenčního pohybového programu na aktivitu a balanci autonomního nervového systému – průběžné výsledky
Year: 2023, type: Conference abstract
-
Vliv chemoterapie a následného intervenčního pohybového programu na aktivitu a balanci autonomního nervového systému – průběžné výsledky
XLVII. Brněnské onkologické dny XXXVII., Konference pro nelékařské zdravotnické pracovníky, Laboratorní diagnostika v onkologii 2023. Sborník abstrakt., year: 2023
2022
-
Impact of Cancer and 12 Weeks of Chemotherapy on the Balance of the Autonomic Nervous System in Cancer Patients
Studia sportiva, year: 2022, volume: 16, edition: 2, DOI
-
Imunoterapie v léčbě kolorektálního karcinomu
Farmakoterapie, year: 2022, volume: 2022, edition: 2
-
Incidence of fatigue associated with immune checkpoint inhibitors in patients with cancer: a meta-analysis
ESMO OPEN, year: 2022, volume: 7, edition: 3, DOI
-
Insomnia in patients treated with checkpoint inhibitors for cancer: A meta-analysis
Frontiers in Oncology, year: 2022, volume: 12, edition: August 2022, DOI
-
Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma
Pharmacological Reports, year: 2022, volume: 74, edition: 1, DOI